99 related articles for article (PubMed ID: 7787748)
21. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
22. Detection of the cell death-inducing protein BAK in Reed-Sternberg cells of Hodgkin's disease.
Brousset P; Krajewski S; Schlaifer D; Reed JC; Delsol G
Leuk Lymphoma; 1999 Aug; 34(5-6):581-4. PubMed ID: 10492082
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's disease after renal transplantation.
Garnier JL; Lebranchu Y; Lefrançois N; Martin X; Dubernard JM; Berger F; Touraine JL
Transplant Proc; 1995 Apr; 27(2):1785. PubMed ID: 7725504
[No Abstract] [Full Text] [Related]
24. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
[TBL] [Abstract][Full Text] [Related]
25. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease.
Chilosi M; Doglioni C; Menestrina F; Montagna L; Rigo A; Lestani M; Barbareschi M; Scarpa A; Mariuzzi GM; Pizzolo G
Blood; 1994 Dec; 84(12):4295-300. PubMed ID: 7994045
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus in Hodgkin's disease.
Herbst H
Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
[TBL] [Abstract][Full Text] [Related]
27. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
30. Report on the workshop biology of the Third International Symposium on Hodgkin's Lymphoma in Cologne 1995.
Wolf J; Bohlen H; Diehl V
Ann Oncol; 1996; 7 Suppl 4():45-7. PubMed ID: 8836409
[TBL] [Abstract][Full Text] [Related]
31. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.
Khan G; Coates PJ
J Pathol; 1994 Nov; 174(3):141-9. PubMed ID: 7823246
[No Abstract] [Full Text] [Related]
32. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
[TBL] [Abstract][Full Text] [Related]
33. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
[TBL] [Abstract][Full Text] [Related]
34. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
35. Mitotic activity and nuclear DNA damage of large cells in Hodgkin's disease: comparison with the expression of p53 and bcl-2 proteins and the presence of Epstein-Barr virus.
Leoncini L; Spina D; Close P; Minacci C; Megha T; De Luca F; Tosi P; Pileri S; Kraft R; Laissue JA; Cottier H
Leuk Lymphoma; 1997 Mar; 25(1-2):153-61. PubMed ID: 9130623
[TBL] [Abstract][Full Text] [Related]
36. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
[TBL] [Abstract][Full Text] [Related]
37. Reappraisal of the relationship between immunoglobulin heavy chain gene rearrangement and Epstein-Barr virus infection in Reed-Sternberg cells of Hodgkin's disease.
Mikata A; Li DX; Kurosu K; Oda K; Yumoto N; Tamaru JI
Leuk Lymphoma; 1997 Dec; 28(1-2):145-52. PubMed ID: 9498713
[TBL] [Abstract][Full Text] [Related]
38. Study of association of Epstein Barr-virus with Hodgkin's disease.
Radha K; Shanthi P; Madhavan M; Senthamarai A
Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
[TBL] [Abstract][Full Text] [Related]
39. Viruses and Hodgkin's disease.
Jarrett RF
Leukemia; 1993 Aug; 7 Suppl 2():S78-82. PubMed ID: 8395622
[TBL] [Abstract][Full Text] [Related]
40. Dual variant of Epstein-Barr virus in Hodgkin/Reed-Sternberg cells: single-cell PCR study on latent membrane protein-1 gene.
Kim LH; Peh SC; Poppema S
Int J Cancer; 2003 Nov; 107(2):250-5. PubMed ID: 12949802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
